Actions of epoxygenase metabolites on the preglomerular vasculature

Journal of the American Society of Nephrology

Volumn 7, Issue 11, 1996, Pages 2364-2370

  Imig, John D ^a   Navar, L G ^a   Roman, Richard J ^b   Reddy, K Kishta ^c   Falck, John R ^c  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Afferent arteriole; Cyclooxygenase; Endothelium; Epoxyelcosatrienoic acid; Kidney

Indexed keywords

14,15 EPOXY 5,8,11 ICOSATRIENOIC ACID; 5,6 EPOXY 8,11,14 ICOSATRIENOIC ACID; 7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; ARACHIDONIC ACID; ICOSATRIENOIC ACID; INDOMETACIN; PROSTAGLANDIN SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIOLE; ARTICLE; KIDNEY; KIDNEY BLOOD FLOW; MALE; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; RAT; STEREOCHEMISTRY; VASOCONSTRICTION; VASODILATATION;

EID: 0030358016     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Gebremedhin D, Ma YH, Imig JD, Harder DR, Roman RJ: Role of cytochrome P-450 in elevating renal vascular tone in spontaneously hypertensive rats. J Vasc Res 1993;30: 53-60.
2. Knickle LC, Webb CD, House AA, Bend JR: Mechanism-based inactivation of cytochrome P-450 1A1 by N-aralkyl-1-aminobenzotriazoles in guinea pig kidney in vivo and in vitro: minimal effects on metabolism of arachidonic acid by renal P450-dependent monooxygenases. J Pharmacol Exp Ther 1993;267:758-764.
3. Takahashi K, Capdevila J, Karara A, Falck JR, Jacobson HR, Badr KF: Cytochrome P-450 arachidonate metabolites in rat kidney: characterization and hemodynamic responses. Am J Physiol 1990;258:F781-F789.
4. Karara A, Makita K, Jacobson HR, Falck JR, Guengerich FP, DuBois RN, Capdevila JH: Molecular cloning, expression, and enzymatic characterization of the rat kidney cytochrome P-450 arachidonic acid epoxygenase. J Biol Chem 1993;268:13565-13570.
5. Karara A, Dishman E, Jacobson H, Falck JR, Capdevila J: Stereochemical analysis of endogenous epoxyeicosatrienoic acids of human kidney cortex. J Biol Chem 1993;268:24543-24546.
6. Sacerdoti D, Abraham NG, McGiff JC, Schwartzman ML: Renal cytochrome P450-dependent metabolism of arachidonic acid in spontaneously hypertensive rats. Biochem Pharmacol 1988;37:521-527.
7. Capdevila J, Wei S, Yan J, et al.: Cytochrome P-450 arachidonic acid epoxygenase: regulatory control of the renal epoxygenase by dietary salt loading. J Biol Chem 1992;267:21720-21726.
8. Makita K, Takahashi K, Karara A, Jacobson HR, Falck JR, Capdevila JH: Experimental and/or genetically controlled alterations of the renal microsomal cytochrome P450 epoxygenase induce hypertension in rats fed a high salt diet. J Clin Invest 1994;94:2414-2420.
9. Takahashi K, Harris RC, Capdevila JH, et al.: Induction of renal arachidonate cytochrome P-450 epoxygenase after uninephrectomy: Counterregulation of hyperfiltration. J Am Soc Nephrol 1993;3:1496-1500.
10. Imakoka S, Nakamura M, Ishizaki T, et al.: Regulation of renal cytochrome P450s by thyroid hormone in diabetic rats. Biochem Pharmacol 1993;46:2197-2200.
11. Carroll MA, Garcia MP, Falck JR, McGiff JC: Cyclooxygenase dependency of the renovascular actions of cytochrome P450-derived arachidonate metabolites. J Pharmacol Exp Ther 1992;260:104-109.
12. Sakairi Y, Jacobson HR, Noland TD, Capdevila JH, Falck JR, Breyer MD: 5.6-EET inhibits ion transport in collecting duct by stimulating endogenous prostaglandin synthesis. Am J Physiol 1995;268:F931-F939.
13. Schlondorff D, Petty E, Oates JA, Jacoby M, Levine SD: Epoxygenase metabolites of arachidonic acid inhibit vasopressin response in toad bladder. Am J Physiol 1987; 253:F464-F470.
14. Madhun ZT, Goldthwait DA, McKay D, Hopfer U, Douglas JG: An epoxygenase metabolite of arachidonic acid mediates angiotensin II-induced rises in cytosolic calcium in rabbit proximal tubule epithelial cells. J Clin Invest 1991;88:456-461.
15. Rosolowsky M, Campbell WB: Synthesis of hydroxyeicosatraenoic (HETEs) and epoxyeicosatrienoic acids (EETs) by cultured bovine coronary artery endothelial cells. Biochim Biophys Acta 1996;1299:267-277.
16. Pfister SL, Falck JR, Campbell WB: Enhanced synthesis of epoxyeicosatrienoic acids by cholesterol-fed rabbit aorta. Am J Physiol 1991;261:H843-H852.
17. Moore SA, Spector AA, Hart MN: Eicosanoid metabolism in cerbromicrovascular endothelium. Am J Physiol 1998;254:C37-C44.
18. Harder DR, Campbell WB, Roman RJ: Role of cytochrome P-450 enzymes and metabolites of arachidonic acid in the control of vascular tone. J Vasc Res 1995;32: 79-92.
19. Imig JD, Navar LG: Afferent arteriolar response to arachidonic acid: Involvement of metabolic pathways. Am J Physiol 1996;271:F87-F93.
20. Katoh T, Takahashi K, Capdevila J, et al.: Glomerular stereospecific synthesis and hemodynamic actions of 8,9-epoxyeicosatrienoic acid in the rat kidney. Am J Physiol 1991;261:F578-F586.
21. Carroll MA, Balazy M, Margiotta P, Falck JR, McGiff JC: Renal vasodilator activity of 5,6-epoxyeicosatrienoic acid depends upon conversion by cyclooxygenase and release of prostaglandins. J Biol Chem 1993;268:12260-12266.
22. +-channel activity. Am J Physiol 1996;270: F822-F832.
23. Imig JD, Gebremedhin D, Harder DR, Roman RJ: Modulation of vascular tone in renal microcirculation by erythrocytes: role of EDRF. Am J Physiol 1993;264: H190-H195.
24. Casellas D, Navar LG: In vitro perfusion of juxtamedullary nephrons from rat. Am J Physiol 1984;246:F349-F358.
25. Falck JR, Yadagiri P, Capdevila J: Synthesis of epoxyeicosatrienoic acids and heteroatom analogs. Methods Enzymol 1990;187:357-364.
26. Capdevila JH, Dishman E, Karara A, Falck JR: Cytochrome P450 arachidonic acid epoxygenase: Stereochemical characterization of epoxyeicosatrienoic acids. Methods Enzymol 1991;206:441-453.
27. Ma Y H, Gebremedhin D, Schwartzman ML, et al.: 20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries. Circ Res 1993;72:126-136.
28. Imig JD, Gebremedhin D, Zou AP, et al.: Formation and actions of 20-hydroxyeicosatetraenoic acid in the renal microcirculation. Am J Physiol 1996;270:R217-R227.
29. Ogletree ML, Harris DN, Greenberg R, Haslanger MF, Nakane M: Pharmacological actions of SQ 29,548, a novel selective thromboxane antagonist. J Pharmacol Exp Ther 1985;234:435-441.
30. Schwartzman ML, Abraham NG, Carroll MA, Levere RD, McGiff JC: Regulation of arachidonic acid metabolism by cytochrome P-450 in rabbit kidney. Biochem J 1986; 238:283-290.
31. Capdevila JH, Jacobson H, Zeldin D: Molecular cloning, expression and enzymatic characterization of a human kidney cytochrome P450 arachidonic acid epoxygenase [Abstract]. J Am Soc Nephrol 1994;5:677.
32. Ma YH, Schwartzman ML, Roman RJ: Altered renal P-450 metabolism of arachidonic acid in Dahl salt-sensitive rats. Am J Physiol 1994;267:R579-R589.
33. Carroll MA, Schwartzman M, Capdevila J, Falck JR, McGiff JC: Vasoactivity of arachidonic acid epoxides. Eur J Pharmacol 1987;138:281-283.
34. Proctor KG, Falck JR, Capdevila J: Intestinal vasodilation by epoxyeicosatrienoic acids: Arachidonic acid metabolites produced by cytochrome P-450 monooxygenase. Circ Res 1987;60:50-59.
35. 2 and epoxyeicosatrienoic acids in relaxation of bovine coronary arteries to arachidonic acid. Am J Physiol 1993;264:H327-H335.
36. Gebremedhin D, Ma YH, Roman RJ, VanRollins M, Harder DR: Cellular mechanisms of cerebral epoxyeicosatrienoic acids on cerebral arterial smooth muscle. Am J Physiol 1992;263:H519-H525.
37. Ellis EF, Police RJ, Yancey L, McKinney JS, Amruthesh SC: Dilation of cerebral arterioles by cytochrome P-450 metabolites of arachidonic acid. Am J Physiol 1990;259: H1171-H1172.
38. + channels in rat renal arterioles. Am J Physiol 1996; 270:F69-F81.
39. + channel in vascular smooth muscles by cytochrome P450 metabolites of arachidonic acid. Eur J Pharmacol 1993;230:215-221.
40. Hecker M, Bara AT, Bauersachs J, Busse R: Characterization of endothelium-derived hyperpolarizing factor as a cytochrome p450-derived arachidonic acid metabolite in mammals. J Physiol 1994;481:407-414.
41. Campbell WB, Gebremedhin D, Pratt PF, Harder DR: Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res 1996;78: 415-423.
42. Fulton D, McGiff JC, Quilley J: Contribution of nitric oxide and cytochrome P450 to the vasodilator effect of bradykinin in the rat kidney. Br J Pharmacol 1992;107: 722-725.
43. Balazy M: Metabolism of 5,6-epoxyeicosatrienoic acid by the human platelet: Formation of novel thromboxane analogs. J Biol Chem 1991;266:23561-23567.
44. Fulton D, Balazy M, McGiff JC, Quilley J: Possible contribution of platelet cyclooxygenase to the renal vascular action of 5,6 epoxyeicosatrienoic acid. J Pharmacol Exp Ther 1996;277:1195-1199.